AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 150 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,502,000 | +57.5% | 144,877 | +25.2% | 0.00% | +50.0% |
| Q3 2019 | $2,224,000 | -30.8% | 115,720 | +6.4% | 0.00% | -33.3% |
| Q2 2019 | $3,213,000 | -19.5% | 108,735 | +29.4% | 0.00% | -25.0% |
| Q1 2019 | $3,991,000 | +23.6% | 84,015 | -6.1% | 0.00% | 0.0% |
| Q4 2018 | $3,228,000 | -29.1% | 89,429 | +20.9% | 0.00% | 0.0% |
| Q3 2018 | $4,552,000 | -6.5% | 73,957 | +2.6% | 0.00% | -20.0% |
| Q2 2018 | $4,867,000 | +59.3% | 72,057 | +27.9% | 0.01% | +66.7% |
| Q1 2018 | $3,056,000 | +52.3% | 56,339 | +67.7% | 0.00% | +50.0% |
| Q4 2017 | $2,007,000 | +70.4% | 33,588 | +38.6% | 0.00% | +100.0% |
| Q3 2017 | $1,178,000 | -6.7% | 24,236 | +0.9% | 0.00% | 0.0% |
| Q2 2017 | $1,262,000 | -40.9% | 24,008 | -49.0% | 0.00% | -50.0% |
| Q1 2017 | $2,137,000 | +19.3% | 47,119 | -0.4% | 0.00% | 0.0% |
| Q4 2016 | $1,791,000 | -5.5% | 47,314 | -5.8% | 0.00% | 0.0% |
| Q3 2016 | $1,895,000 | -48.2% | 50,206 | -57.0% | 0.00% | -50.0% |
| Q1 2015 | $3,661,000 | – | 116,829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |